Samchundang Pharm shortens acquisition date of DHP Korea

Published: 2013-08-21 06:57:00

Updated: 2013-08-21 06:57:00

Samchung Pharm plans to shorten the acquisition date of DHP Korea from Nov. 20 to Nov. 12 in a bid to ensure better liquid assets, map-out of new facility investment and maximization of shareholders’ value, the company said in a regulatory filing on Monday.

Last December, Samchundang reached a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK